Breaking News Instant updates and real-time market news.

XXII

22nd Century

$3.17 /

-0.15 (-4.52%)

08:21
07/23/21
07/23
08:21
07/23/21
08:21

Cowen starts 22nd Century at Outperform ahead of 'major' catalysts

Cowen analyst Vivien Azer initiated coverage of 22nd Century with an Outperform rating and $5 price target. As a leader in plant genetics, 22nd Century positioned to capitalized on "major near-term commercialization catalysts," including potential FDA Modified Risk Tobacco Products designation for its VLN cigarettes and the monetization of its biosynthesis intellectual property starting in the second half of 2021 as well as longer term tobacco regulatory tailwinds, Azer tells investors in a research note.

  • 05

    Aug

XXII 22nd Century
$3.17 /

-0.15 (-4.52%)

07/23/21 Cowen
22nd Century initiated with an Outperform at Cowen

TODAY'S FREE FLY STORIES

Hot Stocks
Immunocore presents data on tebentafusp in reducing ctDNA » 07:07
09/20/21
09/20
07:07
09/20/21
07:07
IMCR

Immunocore

$34.46 /

+2.01 (+6.19%)

Immunocore Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

  • 05
    Feb
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

Hot Stocks
Live Oak Acquisition II extends tender offer related to combination with Navitas » 07:06
09/20/21
09/20
07:06
09/20/21
07:06
LOKB

Live Oak Acquisition II

$9.98 /

-0.005 (-0.05%)

Live Oak Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

09/01/21 Craig-Hallum
Live Oak Acquisition II initiated with a Buy at Craig-Hallum
LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

Hot Stocks
Universal Stainless & Alloy announces base price increase on long products » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
USAP

Universal Stainless & Alloy

$10.77 /

+0.36 (+3.46%)

Universal Stainless &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAP Universal Stainless & Alloy
$10.77 /

+0.36 (+3.46%)

USAP Universal Stainless & Alloy
$10.77 /

+0.36 (+3.46%)

Hot Stocks
Verastem announces clinical collaboration with Amgen in NSCLC treatment » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
VSTM

Verastem

$2.76 /

+0.06 (+2.23%)

, AMGN

Amgen

$219.52 /

+2.18 (+1.00%)

Verastem (VSTM) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

07/01/21 Alliance Global Partners
Verastem initiated with a Buy at Alliance Global Partners
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
AMGN Amgen
$219.52 /

+2.18 (+1.00%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Amgen to Equal Weight, sees better risk/reward elsewhere
09/07/21 Morgan Stanley
Amgen downgraded to Equal Weight from Overweight at Morgan Stanley
08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

Hot Stocks
Miromatrix Medical added to Russell Microcap Index » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
MIRO

Miromatrix Medical

$7.14 /

-0.61 (-7.87%)

Miromatrix Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

07/19/21 Craig-Hallum
Craig-Hallum bullish on Miromatrix Medical, initiates with a Buy
07/19/21 Craig-Hallum
Miromatrix Medical initiated with a Buy at Craig-Hallum
  • 24
    Jun
MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

Hot Stocks
Farmland Partners shares impact from Hurricanes Ida, Nicholas » 07:04
09/20/21
09/20
07:04
09/20/21
07:04
FPI

Farmland Partners

$12.47 /

-0.21 (-1.66%)

Farmland Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

03/26/21 B. Riley Securities
Farmland Partners price target raised to $11.50 from $8.50 at B. Riley
11/25/20 B. Riley Securities
Farmland Partners price target raised to $8.50 from $7 at B. Riley Securities
FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

Hot Stocks
Landos, Icahn School of Medicine to collaborate on Omilancor Phase 2 study » 07:04
09/20/21
09/20
07:04
09/20/21
07:04
LABP

Landos Biopharma

$15.41 /

+0.14 (+0.92%)

Landos Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

  • 04
    Feb
Initiation
Clarus Therapeutics initiated with an Overweight at Cantor Fitzgerald » 07:03
09/20/21
09/20
07:03
09/20/21
07:03
CRXT

Clarus Therapeutics

$8.78 /

+0.98 (+12.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRXT Clarus Therapeutics
$8.78 /

+0.98 (+12.56%)

CRXT Clarus Therapeutics
$8.78 /

+0.98 (+12.56%)

06:05 Today Cantor Fitzgerald
Clarus Therapeutics initiated with an Overweight at Cantor Fitzgerald
Hot Stocks
Plus Products announces launch of Dual Action Sleep Gummies » 07:02
09/20/21
09/20
07:02
09/20/21
07:02
PLPRF

Plus Products

/

+

Plus Products announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLPRF Plus Products
/

+

PLPRF Plus Products
/

+

10/15/20 Roth Capital
TFF Pharmaceuticals price target raised to $23 from $18 at Roth Capital
PLPRF Plus Products
/

+

Upgrade
Tryg upgraded to Neutral from Underperform at Credit Suisse » 07:02
09/20/21
09/20
07:02
09/20/21
07:02
TGVSF

Tryg

$23.82 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGVSF Tryg
$23.82 /

+ (+0.00%)

06/18/21 Morgan Stanley
Tryg resumed with an Equal Weight at Morgan Stanley
03/16/21 Citi
Tryg upgraded to Buy from Neutral at Citi
Hot Stocks
Bristol-Myers: FDA accepts priority review for relatlimab/nivolumab BLA » 07:01
09/20/21
09/20
07:01
09/20/21
07:01
BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

Recommendations
Las Vegas Sands price target lowered to $42 from $53 at Morgan Stanley » 07:00
09/20/21
09/20
07:00
09/20/21
07:00
LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

Recommendations
Morgan Stanley cuts Wynn Resorts price target to $113, but says 'worth the risk' » 06:59
09/20/21
09/20
06:59
09/20/21
06:59
WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

  • 09
    Feb
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

Upgrade
Methanex upgraded to Outperform from Sector Perform at Scotiabank » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
MEOH

Methanex

$42.90 /

+1.3 (+3.13%)

Scotiabank analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

MEOH Methanex
$42.90 /

+1.3 (+3.13%)

09/13/21 Piper Sandler
Methanex initiated with a Neutral at Piper Sandler
09/07/21 Barclays
Methanex upgraded to Overweight from Equal Weight at Barclays
09/01/21 RBC Capital
Methanex to generate strong cash flows in 2021-22, says RBC Capital
07/19/21 TD Securities
Methanex price target raised to $54 from $51 at TD Securities
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

Hot Stocks
PyroGenesis joins two FTSE Russell Indexes » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
PYR

PyroGenesis

$4.42 /

+0.1 (+2.31%)

PyroGenesis Canada is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

Hot Stocks
Materion to acquire H.C. Starck's Electronic Materials portfolio » 06:57
09/20/21
09/20
06:57
09/20/21
06:57
MTRN

Materion

$71.29 /

+1.01 (+1.44%)

Materion Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTRN Materion
$71.29 /

+1.01 (+1.44%)

MTRN Materion
$71.29 /

+1.01 (+1.44%)

08/09/21 KeyBanc
Materion downgraded to Sector Weight from Overweight at KeyBanc
05/06/21 Sidoti
Materion reinstated with a Buy at Sidoti
01/26/21 KeyBanc
Materion price target raised to $80 from $68 at KeyBanc
MTRN Materion
$71.29 /

+1.01 (+1.44%)

Initiation
Workday initiated with an Overweight at Wells Fargo » 06:56
09/20/21
09/20
06:56
09/20/21
06:56
WDAY

Workday

$268.56 /

-2.37 (-0.87%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

09/17/21 Barclays
Workday price target raised to $340 from $309 at Barclays
09/09/21 Exane BNP Paribas
Workday upgraded to Outperform from Neutral at Exane BNP Paribas
09/02/21 Jefferies
Workday price target raised to $320 from $300 at Jefferies
09/01/21 Goldman Sachs
Anaplan price target raised to $67 from $59 at Goldman Sachs
WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

WDAY Workday
$268.56 /

-2.37 (-0.87%)

Hot Stocks
CareMax appoints Beatriz Assapimonwait to board of directors » 06:55
09/20/21
09/20
06:55
09/20/21
06:55
CMAX

CareMax

$9.50 /

-0.05 (-0.52%)

CareMax announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMAX CareMax
$9.50 /

-0.05 (-0.52%)

CMAX CareMax
$9.50 /

-0.05 (-0.52%)

09/13/21
Fly Intel: Top five analyst upgrades
09/13/21 Piper Sandler
CareMax upgraded to Overweight from Neutral at Piper Sandler
09/09/21 Cowen
CareMax initiated with an Outperform at Cowen
07/01/21
Fly Intel: Top five analyst initiations
CMAX CareMax
$9.50 /

-0.05 (-0.52%)

General news
FX Update: The dollar and yen have rallied amid acute risk-off positioning » 06:55
09/20/21
09/20
06:55
09/20/21
06:55
$ECON

Economic Data

/

+

FX Update: The dollar and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Initiation
Salesforce initiated with an Overweight at Wells Fargo » 06:54
09/20/21
09/20
06:54
09/20/21
06:54
CRM

Salesforce

$260.52 /

+0.13 (+0.05%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

09/17/21 Barclays
Salesforce price target raised to $330 from $320 at Barclays
08/27/21 Loop Capital
Salesforce price target raised to $265 from $235 at Loop Capital
08/27/21 Societe Generale
Salesforce price target raised to $321 from $290 at Societe Generale
08/26/21 RBC Capital
Salesforce assumed with an Outperform at RBC Capital
CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

CRM Salesforce
$260.52 /

+0.13 (+0.05%)

Initiation
Adobe initiated with an Overweight at Wells Fargo » 06:52
09/20/21
09/20
06:52
09/20/21
06:52
ADBE

Adobe

$655.09 /

-10.26 (-1.54%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

06:26 Today Citi
Adobe shares may be pricing in front office tailwinds, says Citi
09/17/21 Mizuho
Adobe price target raised to $695 from $640 at Mizuho
09/16/21 BMO Capital
Adobe price target raised to $730 from $630 at BMO Capital
09/16/21 Barclays
Adobe price target raised to $740 from $660 at Barclays
ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

ADBE Adobe
$655.09 /

-10.26 (-1.54%)

Hot Stocks
Independence Contract Drilling signs drilling contract to reactivate 16th rig » 06:50
09/20/21
09/20
06:50
09/20/21
06:50
ICD

Independence Contract Drilling

$2.74 /

-0.02 (-0.72%)

Independence Contract…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Hot Stocks
    Bridge Specialty Group announces asset acquisition of Gremesco of New Jersey » 06:48
    09/20/21
    09/20
    06:48
    09/20/21
    06:48
    BRO

    Brown & Brown

    $56.96 /

    -0.495 (-0.86%)

    Brown & Brown and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    08/16/21 Wolfe Research
    Brown & Brown initiated with a Peer Perform at Wolfe Research
    07/27/21 Keefe Bruyette
    Keefe Bruyette boosts Brown & Brown target on 'stronger' organic growth
    04/28/21 Deutsche Bank
    Brown & Brown price target raised to $55 from $50 at Deutsche Bank
    04/28/21 RBC Capital
    Brown & Brown price target raised to $53 from $48 at RBC Capital
    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    BRO Brown & Brown
    $56.96 /

    -0.495 (-0.86%)

    Hot Stocks
    Pfizer, BioNTech announce results from trial of COVID-19 vaccine in children » 06:47
    09/20/21
    09/20
    06:47
    09/20/21
    06:47
    PFE

    Pfizer

    $43.89 /

    -0.57 (-1.28%)

    , BNTX

    BioNTech

    $358.75 /

    -13.75 (-3.69%)

    Pfizer Inc. (PFE) and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    06:31 Today Citi
    Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    09/16/21 Canaccord
    Exact Sciences salesforce expansion a net positive, says Canaccord
    09/16/21 BofA
    Moderna boosters already reflected in 'bullish' consensus, says BofA
    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    09/17/21 Evercore ISI
    Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
    08/27/21 UBS
    BioNTech price target raised to $300 from $111 at UBS
    08/20/21 Canaccord
    BioNTech price target raised to $450 from $240 at Canaccord
    08/12/21 Wells Fargo
    Wells says Moderna vaccine looks more effective than Pfizer's against Delta
    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    BNTX BioNTech
    $358.75 /

    -13.75 (-3.69%)

    PFE Pfizer
    $43.89 /

    -0.57 (-1.28%)

    Recommendations
    Molina Healthcare price target raised to $305 from $284 at Mizuho » 06:45
    09/20/21
    09/20
    06:45
    09/20/21
    06:45
    MOH

    Molina Healthcare

    $278.12 /

    +8.09 (+3.00%)

    Mizuho analyst Ann Hynes…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    09/09/21 Cowen
    Molina Healthcare initiated with an Outperform at Cowen
    09/08/21 Mizuho
    Selloff in managed care sector overdone, says Mizuho
    07/30/21 BMO Capital
    Molina Healthcare price target raised to $315 from $300 at BMO Capital
    07/30/21 Mizuho
    Molina Healthcare price target raised to $284 from $273 at Mizuho
    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    MOH Molina Healthcare
    $278.12 /

    +8.09 (+3.00%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.